Academy Award winner Charlton Heston, known for his roles in movies like Ben-Hur and The Ten Commandments, was diagnosed with prostate cancer in 1998, just a couple of years after he underwent hip-replacement surgery. After a brief but intense course of radiation, the cancer went into remission — but Heston’s health would never be the same. In 2000, after finishing treatment for his cancer, he entered rehab for alcohol addiction, and in 2002, he announced another, even bigger threat to his health: Alzheimer’s disease. Six years later, at the age of 84, he passed away.
Harry Belafonte — an actor, activist, and singer/songwriter (perhaps best known for “The Banana Boat Song,” with its famous “Day-O” refrain) — added “survivor” to his resume after he fought and beat prostate cancer in 1996. In the years since, Belafonte has been refreshingly candid about his ordeal, even going public about his post-surgery struggles with incontinence, a common side effect that Belafonte said he conquered in less than a year with exercises (such as Kegels). But he wasn’t always so comfortable opening up. “The prostate is something that attacks that central part of the male body that men are very preoccupied with. Somehow, any disorder there means your life is over, you can't be a man anymore, you are now something less,” he explained at a benefit for the Hoag Cancer Center in California, adding that he hoped to change that perception. “If you're going to have [prostate cancer], you're going to have it. It’s what you do about it that makes the difference — how you conduct your life."
Former South African President Nelson Mandela was diagnosed with prostate cancer at age 83 in July 2001, 16 years after he had prostate surgery to remove some benign tumors. Doctors treated the cancer successfully with seven weeks of radiation and said the tumor should not affect Mandela’s life expectancy. More recently, however, the 92-year-old Nobel Peace Prize winner has faced various other health crises, including a collapsed lung and difficulty walking.
Former New York City Mayor Rudy Giuliani knew the heartbreak that prostate cancer could cause even before he was diagnosed in April 2000 — his father had died of the disease 19 years earlier. Determined not to meet the same fate, Giuliani, now 67 and healthy, chose a multi-phase treatment plan that consisted of four months of hormone therapy, implantation of radioactive metal pellets in his prostate (to radiate the cancer), and five weeks of almost-daily external-beam radiation with continuing hormone therapy. The plan was aggressive — but successful. It left the politician in both good health and good spirits. “The time that I spent this morning between 8 and 9 was not nearly as painful as most of my morning meetings,” he joked of his treatments during a press conference after the implant surgery. “And there was less fighting.... So this was actually a much quieter and more peaceful morning than I usually have.”
By Allison Takeda, Senior Editor
Golf legend Arnold Palmer has 62 PGA Tour wins, his own drink (half lemonade, half iced tea), and a place in the World Golf Hall of Fame — but his proudest accomplishment to date is his triumph over prostate cancer. In the years since his 1997 diagnosis and treatment (a radical prostatectomy and radiation), Palmer, 82, has used his celebrity to raise awareness of the disease among other men and to help found the Arnold Palmer Prostate Center, a nonprofit treatment destination at Eisenhower Lucy Curci Cancer Center in Rancho Mirage, Calif. He’s adamant that all men should get screened. “There’s nothing better than going to the doctor and knowing just exactly where you stand,” he told Everyday Health. “That’s so important for men to do. Don’t think about doing it. Just do it.”
Actor/director Dennis Hopper, who appeared in movies including Easy Rider and Hoosiers, died from prostate cancer in May 2010, less than nine months after being diagnosed. In January of that year, he discovered that the cancer had metastasized to his bones, and by March, he was too weak to continue chemotherapy. Before he died, however, he was immortalized with a star on the Hollywood Walk of Fame — a fitting end to a long and fruitful career.
source: When Celebrities Get Prostate Cancer
14 Famous Men Who Battled Prostate Cancer
Cancer doesn't care if you're rich and famous: Not even stars like Robert De Niro or Sir Ian McKellen are immune from the disease.
By Allison Takeda, Senior Editor
James Brown, the "Godfather of Soul," lived up to his reputation as the hardest-working man in show business even after he announced in December 2004 that he had been diagnosed with prostate cancer and would undergo surgery later that month. Within a few weeks of his radical prostatectomy, he was back onstage for his "Seven Decades of Funk" world tour. "When they found the cancer, they said it was in the early stages and I thank God for that," Brown said in an interview for Coping With Cancer magazine. "Right now, the word from ol' James Brown is 'I feel good!' I just trust in God and trust in my doctors." Sadly, the music legend died two years later of congestive heart failure.
I will say I was wrong now if we can get to $45!
jacosa, i am thinking the move to the upside could be 12-15$ on + news
may just be typical for "gub'ment" to be a few days later than expected. either way the news will move the stock significantly imho.
For its PROCEDE 500 study published in the journal Current Medical Research and Opinion, Myriad found that 65% of physicians changed their initial treatment plan for prostate cancer patients based on results from the Prolaris test. Overall, this amounted to a 50% drop in surgical interventions and a 30% reduction in radiation treatment. What's more, almost all of the patients in the study who had "undecided" treatment plans picked noninterventional options after getting their Prolaris score, the company said.
Michael Brawer, vice president of medical affairs at Myriad Genetic Laboratories, said in a statement that by reducing unnecessary surgeries or radiation treatment and boosting procedures for men with aggressive prostate cancer, the Prolaris test provides better care and is cost-effective.
"We believe [it] will save and improve more lives and potentially save the healthcare system more money," he said.
Myriad Publishes Clinical Utility Study for Prolaris(R)
Myriad Submits Updated Dossier for Medicare Reimbursement
SALT LAKE CITY, March 3, 2014 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it has published data from the PROCEDE 500 study in the journal Current Medical Research and Opinion, demonstrating that 65 percent of physicians changed their original treatment plans for men with prostate cancer based on results from the Prolaris test. Prolaris is a 46-gene molecular diagnostic test that has been evaluated in 11 clinical studies with more than 5,000 patients.
"Prolaris is an absolute game changer for urologists because it adds meaningful new prognostic information in terms of risk assessment for prostate cancer patients that will improve their care," said E. David Crawford, M.D., head of the Section of Urologic Oncology at the University of Colorado. "In this study, Prolaris led to major changes in therapies with significant reductions or increases in interventional treatments that were based on patients' unique risk profiles."
PROCEDE 500 is a prospective registry study that was designed to evaluate the impact of the Prolaris test on physician treatment recommendations for patients with prostate cancer. In this study of 305 patients, physicians said they would change their treatment plans in 65 percent of cases after receiving the Prolaris report - 40 percent of patients had a reduction in therapeutic burden, while 25 percent had an increase in therapeutic burden - independent of treatment strategy (i.e., surgery and/or radiation vs. active surveillance and/or watchful waiting).
June 04, 2014
Guest Post: Myriad -- An Obvious and Patent-Friendly Interpretation
By Paul Cole* --